Qualigen Therapeutics(US:QLGN) Sou Hu Cai Jing·2025-09-20 09:50Core Viewpoint - Faraday Future (FF) announced a strategic investment in Qualigen Therapeutics, Inc. (QLGN) to enhance its Crypto and Web3 business initiatives, with an investment amount exceeding $41 million [1][5]. Group 1: Strategic Investment - FF is leading a strategic investment in QLGN, with participation from various investors including Binance Labs and Sequoia Capital, aiming to create a bridge between Web2 and Web3 [1][5]. - The investment is expected to exceed $41 million, with FF founder Jia Yueting personally investing $4 million and voluntarily locking his shares for two years [1][5][9]. - Following the investment, FF and Jia Yueting will collectively hold approximately 62% of QLGN's shares [5][6]. Group 2: Business Development - QLGN will be renamed CXC10 and will focus on developing six major products under the Crypto "three-horse carriage" business model [7]. - The company aims to become the first stock in the U.S. that integrates Web2+Web3 and AI+Crypto [5][7]. - C10 Treasury has already completed approximately $10 million in crypto asset allocation, achieving a floating profit of about 7% [8]. Group 3: Leadership and Governance - Jia Yueting will serve as the chief advisor for QLGN, while FF's global president Jerry Wang will take on the role of Co-CEO [6]. - After the completion of the transaction, FF will have the right to nominate two out of five independent board seats, potentially increasing to four out of seven after shareholder approval [6]. Group 4: Debt Management - Jia Yueting announced the establishment of a second creditor trust, committing half of his equity incentives and personal investment returns to repay debts under Chinese law, while the other half will be used for vehicle production [9].